Exocobio Is A Global Leader In Exosome Based Biomedicine And Regenerative Aestheticsdedicated To Enhancing Human Health Through Research And Innovationfounded In 2017 And Headquartered In Seoulsouth Koreathe Company Specializes In Developing Cosmeceutical And Biopharmaceutical Products Derived From Stem Cell Exosomesexocobio Operates The World S First Stem Cell Exosome Manufacturing Facilityexogmpa Cshowcasing Its Pioneering Role In This Field The Company Focuses On Creating Innovative Therapeutics And Cosmetic Products That Leverage The Potential Of Exosomes For Regenerative And Aesthetic Applicationswith Significant Funding Of Approximately $56 3 Million And A Valuation Of $135 Million As Of August 2020Exocobio Is Well Positioned For Ongoing Research And Development In Exosome Technologyled By President & Ceo Byeong Seong Chothe Company Employs Between 100 To 200 Peoplereflecting Its Growth In The Biotechnology Sector
